136 related articles for article (PubMed ID: 2095206)
1. Preparation and characterization of paramagnetic polychelates and their protein conjugates.
Sieving PF; Watson AD; Rocklage SM
Bioconjug Chem; 1990; 1(1):65-71. PubMed ID: 2095206
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.
Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM
Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062
[TBL] [Abstract][Full Text] [Related]
3. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
4. Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma.
Curtet C; Maton F; Havet T; Slinkin M; Mishra A; Chatal JF; Muller RN
Invest Radiol; 1998 Oct; 33(10):752-61. PubMed ID: 9788138
[TBL] [Abstract][Full Text] [Related]
5. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
Anelli PL; Lattuada L; Lorusso V; Lux G; Morisetti A; Morosini P; Serleti M; Uggeri F
J Med Chem; 2004 Jul; 47(14):3629-41. PubMed ID: 15214790
[TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
[TBL] [Abstract][Full Text] [Related]
7. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN
Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium cryptelates as MR contrast agents.
Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
[TBL] [Abstract][Full Text] [Related]
9. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
[TBL] [Abstract][Full Text] [Related]
10. Contrast agents for magnetic resonance angiographic applications: 1H and 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin.
Aime S; Chiaussa M; Digilio G; Gianolio E; Terreno E
J Biol Inorg Chem; 1999 Dec; 4(6):766-74. PubMed ID: 10631608
[TBL] [Abstract][Full Text] [Related]
11. Clearance of liposomal gadolinium: in vivo decomplexation.
Unger EC; Fritz TA; Tilcock C; New TE
J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
Martin VV; Ralston WH; Hynes MR; Keana JF
Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
[TBL] [Abstract][Full Text] [Related]
13. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals.
Baxter AB; Melnikoff S; Stites DP; Brasch RC
Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium and dysprosium chelates of DTPA-amide-dextran: synthesis, 1H NMR relaxivity, and induced 23Na NMR shift.
Chu WJ; Elgavish GA
NMR Biomed; 1995 Jun; 8(4):159-63. PubMed ID: 8771090
[TBL] [Abstract][Full Text] [Related]
16. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
17. Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes.
Duncan JR; Franano FN; Edwards WB; Welch MJ
Invest Radiol; 1994 Jun; 29 Suppl 2():S58-61. PubMed ID: 7928272
[No Abstract] [Full Text] [Related]
18. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
19. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
20. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
